Qube Research & Technologies (QRT)
GTHX

Qube Research & Technologies (QRT)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-800,511
Closed -$1.83M – 4324
2024
Q2 		$1.83M Buy
800,511
+476,045
+147% +$1.82M ﹤0.01% 1677
2024
Q1 		$1.4M Buy
324,466
+277,170
+586% +$966K ﹤0.01% 1947
2023
Q4 		$144K Buy
+47,296
New +$88.9K ﹤0.01% 2956
2023
Q2 		– Sell
-214,224
Closed -$574K – 3153
2023
Q1 		$574K Sell
214,224
-185,797
-46% -$893K ﹤0.01% 1515
2022
Q4 		$2.17M Buy
400,021
+309,012
+340% +$2.59M 0.01% 920
2022
Q3 		$1.14M Buy
91,009
+25,171
+38% +$288K 0.01% 1155
2022
Q2 		$325K Buy
65,838
+49,216
+296% +$273K ﹤0.01% 1562
2022
Q1 		$126K Sell
16,622
-14,825
-47% -$141K ﹤0.01% 2031
2021
Q4 		$321K Buy
+31,447
New +$401K ﹤0.01% 1783

Qube Research & Technologies (QRT)'s GTHX Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 800,511 shares — an estimated $1.83M sold.

Qube Research & Technologies (QRT) first reported a position in GTHX in Q4 2021 and held it in 9 quarters. The position peaked at $2.17M in Q4 2022. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 800,511 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $1.83M.
  • Qube Research & Technologies (QRT) first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s G1 Therapeutics, Inc. Common Stock position peaked at $2.17M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.